Matthew McAviney, New Enterprise

Matthew McAviney is a Partner at New Enterprise Associates (NEA) on the healthcare team. See sector focus and contact routes.

About Matthew McAviney

Matthew McAviney is a Partner at New Enterprise Associates (NEA) on the healthcare team, focusing specifically on biopharma investments since joining the firm in 2018. His investment thesis targets transformative healthcare opportunities across Seed, Series A, and select Series B stages, primarily within the biopharma sector. McAviney typically invests in check sizes ranging from $2.0 million to $50.0 million, leveraging his dual expertise as a practicing physician (M.D.) and MBA graduate to evaluate therapeutic ventures. Notable portfolio companies he has supported include AviadoBio, Apellis, Denali, and Semma, the latter of which he helped build during his prior role as a Principal at F-Prime Capital. His distinctive point of view stems from over a decade of experience spanning medicine, equity research at Robert W. Baird, and healthcare strategy consulting at Oliver Wyman, giving him a unique perspective on new therapeutic opportunities. McAviney is based in San Francisco, California, rather than Cambridge, Massachusetts, applying his background in lipid metabolism research and clinical practice to identify high-impact biopharma deals.

Matthew McAviney at a glance

Role
Partner
Organization
New Enterprise Associates
Location
Cambridge, Massachusetts, United States
Investor type
Venture Capital
Focus areas
SaaS

Frequently asked about Matthew McAviney

What does Matthew McAviney invest in?
Matthew McAviney at New Enterprise Associates (Cambridge, Massachusetts, United States) — sector focus: SaaS.
How do I contact Matthew McAviney?
Matthew McAviney's published profile links (website, LinkedIn or X where available) are listed on the StartupFundraising.com investor profile.
Where is Matthew McAviney based?
Matthew McAviney is based in Cambridge, Massachusetts, United States.

This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in Cambridge.

Investors similar to Matthew McAviney (20)

Browse related investor lists (2)

Compare Matthew McAviney (8)

Investors like Matthew McAviney · Full investor directory · Investor access · Company funding database

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades